Pages that link to "Raynaud's phenomenon"
Jump to navigation
Jump to search
The following pages link to Raynaud's phenomenon:
Displayed 50 items.
- The Living Guidelines: UA/NSTEMI Recommendations for UA/NSTEMI in Post CABG Patients Polling Results for CLASS IIa Guidelines (← links)
- The Living Guidelines: UA/NSTEMI Recommendations for UA/NSTEMI in Post CABG Patients Suggest Revisions to the CLASS IIa Guidelines (← links)
- The Living Guidelines: UA/NSTEMI Recommendations for UA/NSTEMI in Elderly Suggest Revisions to the CLASS I Guidelines (← links)
- The Living Guidelines: UA/NSTEMI Recommendations for UA/NSTEMI in Elderly Polling Results for CLASS I Guidelines (← links)
- The Living Guidelines: UA/NSTEMI Recommendations for UA/NSTEMI in Chronic Kidney Disease Suggest Revisions to the CLASS I Guidelines (← links)
- The Living Guidelines: UA/NSTEMI Recommendations for UA/NSTEMI in Chronic Kidney Disease Polling Results for CLASS I Guidelines (← links)
- The Living Guidelines: Recommendations for UA/NSTEMI in Drug and Substance Abusers Suggest Revisions to the CLASS I Guidelines (← links)
- The Living Guidelines: UA/NSTEMI Recommendations for UA/NSTEMI in Drug and Substance Abusers Polling Results for CLASS I Guidelines (← links)
- The Living Guidelines: Recommendations for UA/NSTEMI in Drug and Substance Abusers Suggest Revisions to the CLASS IIa Guidelines (← links)
- The Living Guidelines: Recommendations for UA/NSTEMI in Drug and Substance Abusers Polling Results for CLASS IIa Guidelines (← links)
- The Living Guidelines: Recommendations for UA/NSTEMI in Drug and Substance Abusers Suggest Revisions to the CLASS IIb Guidelines (← links)
- The Living Guidelines: Recommendations for UA/NSTEMI in Drug and Substance Abusers Polling Results for CLASS IIb Guidelines (← links)
- The Living Guidelines: Recommendations for UA/NSTEMI in Drug and Substance Abusers Suggest Revisions to the CLASS III Guidelines (← links)
- The Living Guidelines: Recommendations for UA/NSTEMI in Drug and Substance Abusers Polling Results for CLASS III Guidelines (← links)
- The Living Guidelines: Recommendations for UA/NSTEMI in Prinzmetal’s Angina Suggest Revisions to the CLASS I Guidelines (← links)
- The Living Guidelines: UA/NSTEMI Recommendations for UA/NSTEMI in Prinzmetal’s Angina Polling Results for CLASS I Guidelines (← links)
- The Living Guidelines: Recommendations for UA/NSTEMI in Prinzmetal’s Angina Suggest Revisions to the CLASS IIb Guidelines (← links)
- The Living Guidelines: UA/NSTEMI Recommendations for UA/NSTEMI in Prinzmetal’s Angina Polling Results for CLASS IIb Guidelines (← links)
- The Living Guidelines: Recommendations for UA/NSTEMI in Prinzmetal’s Angina Suggest Revisions to the CLASS III Guidelines (← links)
- The Living Guidelines: UA/NSTEMI Recommendations for UA/NSTEMI in Prinzmetal’s Angina Polling Results for CLASS III Guidelines (← links)
- The Living Guidelines: Recommendations for UA/NSTEMI in patients with Cardiovascular Syndrome X Suggest Revisions to the CLASS I Guidelines (← links)
- The Living Guidelines: UA/NSTEMI Recommendations for UA/NSTEMI in patients with Cardiovascular Syndrome X Polling Results for CLASS I Guidelines (← links)
- The Living Guidelines: Recommendations for UA/NSTEMI in patients with Cardiovascular Syndrome X Suggest Revisions to the CLASS IIb Guidelines (← links)
- The Living Guidelines: UA/NSTEMI Recommendations for UA/NSTEMI in patients with Cardiovascular Syndrome X Polling Results for CLASS III Guidelines (← links)
- The Living Guidelines: Recommendations for UA/NSTEMI in patients with Cardiovascular Syndrome X Suggest Revisions to the CLASS III Guidelines (← links)
- Interferon alfa-2b (← links)
- Raynaud’s phenomenon (redirect page) (← links)
- Dextroamphetamine (← links)
- Methylphenidate (oral) (← links)
- Bleomycin (← links)
- Dorzolamide and Timolol Ophthalmic (← links)
- Pergolide (← links)
- Pramipexole (← links)
- Vinblastine (← links)
- Clonidine (← links)
- ST elevation myocardial infarction beta blocker therapy (← links)
- The heart in mixed connective tissue disorder (← links)
- Thyroid nodule medical therapy (← links)
- Familial mediterranean fever physical examination (← links)
- DURACLON adverse reactions (← links)
- CLONIDINE patch adverse reactions (← links)
- Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate (← links)
- Atenolol (← links)
- Brimonidine (topical) (← links)
- Methylphenidate (transdermal) (← links)
- Antisynthetase syndrome (← links)
- Systemic lupus erythematosus natural history, complications and prognosis (← links)
- Enalaprilat (← links)
- Prehypertension (← links)
- The Living Guidelines: STEMI Recommendations for Inhibition of the Renin-Angiotensin-Aldosterone System Suggest Revisions to the CLASS I Guidelines (← links)
- The Living Guidelines: STEMI Recommendations for Inhibition of the Renin-Angiotensin-Aldosterone System Suggest Revisions to the CLASS IIa Guidelines (← links)
- The Living Guidelines: STEMI Recommendations for Inhibition of the Renin-Angiotensin-Aldosterone System Suggest Revisions to the CLASS IIb Guidelines (← links)
- The Living Guidelines: STEMI Recommendations for Inhibition of the Renin-Angiotensin-Aldosterone System Polling Results for CLASS I Guidelines (← links)
- The Living Guidelines: STEMI Recommendations for Inhibition of the Renin-Angiotensin-Aldosterone System Polling Results for CLASS IIa Guidelines (← links)
- The Living Guidelines: STEMI Recommendations for Inhibition of the Renin-Angiotensin-Aldosterone System Polling Results for CLASS IIb Guidelines (← links)
- The Living Guidelines: Maintenance of sinus rhythm: Polling Results for CLASS III Guidelines (← links)
- The Living Guidelines: Diagnosis and Management of Chronic Heart Failure (← links)
- The Living Guidelines: Initial Clinical Assessment of Patients Presenting with Heart Failure. Polling Results for CLASS I Guidelines (← links)
- The Living Guidelines: Initial Clinical Assessment of Patients Presenting with Heart Failure. Suggest Revisions to the CLASS I Guidelines (← links)
- The Living Guidelines: Initial Clinical Assessment of Patients Presenting with Heart Failure. Suggest Revisions to the CLASS IIa Guidelines (← links)
- The Living Guidelines: Initial Clinical Assessment of Patients Presenting with Heart Failure. Polling Results for CLASS IIa Guidelines (← links)
- The Living Guidelines: Initial Clinical Assessment of Patients Presenting with Heart Failure. Polling Results for CLASS IIb Guidelines (← links)
- The Living Guidelines: Initial Clinical Assessment of Patients Presenting with Heart Failure. Suggest Revisions to the CLASS IIb Guidelines (← links)
- The Living Guidelines: Initial Clinical Assessment of Patients Presenting with Heart Failure. Polling Results for CLASS III Guidelines (← links)
- The Living Guidelines: Initial Clinical Assessment of Patients Presenting with Heart Failure. Suggest Revisions to the CLASS III Guidelines (← links)
- The Living Guidelines: Serial Clinical Assessment of Patients Presenting with Heart Failure. Polling Results for CLASS I Guidelines (← links)
- The Living Guidelines: Serial Clinical Assessment of Patients Presenting with Heart Failure. Suggest Revisions to the CLASS I Guidelines (← links)
- The Living Guidelines: Serial Clinical Assessment of Patients Presenting with Heart Failure. Polling Results for CLASS IIa Guidelines (← links)
- The Living Guidelines: Serial Clinical Assessment of Patients Presenting with Heart Failure. Suggest Revisions to the CLASS IIa Guidelines (← links)
- The Living Guidelines: Serial Clinical Assessment of Patients Presenting with Heart Failure. Polling Results for CLASS IIb Guidelines (← links)